002462 Stock Overview
Engages in the wholesale, retail, and logistics of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Cachet Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.05 |
| 52 Week High | CN¥15.30 |
| 52 Week Low | CN¥9.78 |
| Beta | 0.38 |
| 11 Month Change | 12.58% |
| 3 Month Change | 32.92% |
| 1 Year Change | -6.89% |
| 33 Year Change | 13.58% |
| 5 Year Change | -11.91% |
| Change since IPO | -0.17% |
Recent News & Updates
Shareholder Returns
| 002462 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 7.3% | -2.9% | -3.4% |
| 1Y | -6.9% | -12.7% | 6.1% |
Return vs Industry: 002462 exceeded the CN Healthcare industry which returned -12.7% over the past year.
Return vs Market: 002462 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 002462 volatility | |
|---|---|
| 002462 Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 002462 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002462's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,357 | Yibin Huang | www.cachet.com.cn |
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. It also sells medical devices. Cachet Pharmaceutical Co., Ltd.
Cachet Pharmaceutical Co., Ltd. Fundamentals Summary
| 002462 fundamental statistics | |
|---|---|
| Market cap | CN¥4.03b |
| Earnings (TTM) | CN¥244.17m |
| Revenue (TTM) | CN¥26.70b |
16.8x
P/E Ratio0.2x
P/S RatioIs 002462 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002462 income statement (TTM) | |
|---|---|
| Revenue | CN¥26.70b |
| Cost of Revenue | CN¥25.13b |
| Gross Profit | CN¥1.56b |
| Other Expenses | CN¥1.32b |
| Earnings | CN¥244.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 5.86% |
| Net Profit Margin | 0.91% |
| Debt/Equity Ratio | 45.0% |
How did 002462 perform over the long term?
See historical performance and comparison